Fiblast trafermin: SCIO and partner Wyeth-Ayerst began Phase II tests

Scios Inc. (SCIO), Mountain View, Calif.
Product: Fiblast

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE